This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n6http://linked.opendata.cz/resource/drugbank/drug/DB08516/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08516/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08516/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08516/identifier/pdb/

Statements

Subject Item
n2:DB08516
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB08516 n12:DB08516
dcterms:title
(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]
adms:identifier
n6:23659732 n7:99444987 n8:DB08516 n9:SAG
n3:IUPAC-Name
n4:271B5FB7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5FBD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5FBC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5FB9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5FBA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5FBB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5FB5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5FB3-363D-11E5-9242-09173F13E4C5 n4:271B5FB6-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5FB4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5FC3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5FC4-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5FBE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5FBF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5FC1-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5FC0-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5FC2-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5FC9-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5FCB-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5FCC-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5FC8-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5FC7-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5FCA-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5FB8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5FC5-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5FC6-363D-11E5-9242-09173F13E4C5